Edition:
United Kingdom

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

0.66USD
17 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.66
Open
$0.66
Day's High
$0.66
Day's Low
$0.66
Volume
1,260
Avg. Vol
133,006
52-wk High
$2.04
52-wk Low
$0.53

Latest Key Developments (Source: Significant Developments)

Genetic Technologies ‍Announces Offering Of American Depositary Shares​
Thursday, 23 May 2019 

May 23 (Reuters) - Genetic Technologies Ltd ::INVESTORS TO BUY 1.5 MILLION AMERICAN DEPOSITARY SHARES, REPRESENTING 150 OF ORDINARY SHARES AT $0.80 PER ADS; RAISNG $1.2 MILLION.  Full Article

Genetic Technologies Receives Letter From Nasdaq Stock Market
Friday, 3 May 2019 

May 3 (Reuters) - Genetic Technologies Ltd ::RECEIVED A LETTER FROM NASDAQ STOCK MARKET DATED 29 APRIL 2019.LETTER ADVISES THAT CO'S REPORTED STOCKHOLDERS' EQUITY IS LESS THAN MINIMUM SPECIFIED AMOUNT OF US$2.5 MILLION AS AT DEC 31, 2018.NASDAQ BELIEVES CO NO LONGER COMPLIES WITH A NASDAQ MARKETPLACE LISTING RULE.DEFICIENCY NOTICE DOES NOT IMMEDIATELY AFFECT GTG'S NASDAQ LISTING.SAYS IT WILL SUBMIT REQUIRED PLAN TO NASDAQ WITHIN 45 CALENDAR DAYS TO REGAIN COMPLIANCE .  Full Article

Genetic Technologies Says Paul Viney Will Be Joining Co As Chief Financial Officer
Tuesday, 11 Dec 2018 

Dec 11 (Reuters) - Genetic Technologies Ltd ::PAUL VINEY WILL BE JOINING COMPANY AS CHIEF FINANCIAL OFFICER.  Full Article

Genetic Technologies Signs JV Deal With Beijing Zishan Health Consultancy
Thursday, 16 Aug 2018 

Aug 16 (Reuters) - Genetic Technologies Ltd ::CO SIGNED PROPOSED JOINT VENTURE WITH BEIJING ZISHAN HEALTH CONSULTANCY LIMITED.JV WILL BE OWNED 50 PERCENT BY GTG AND 50 PERCENT BY ZISHAN AND ITS ASSOCIATED ENTITIES.  Full Article

Genetic Technologies Says H1 Comprehensive Loss Attributable $3.3 Mln
Monday, 26 Feb 2018 

Feb 27 (Reuters) - Genetic Technologies Ltd ::H1 REVENUE FROM CONTINUING OPERATIONS - GENETIC TESTING SERVICES $97.8 MILLION VERSUS $369.1 MILLION.‍H1 COMPREHENSIVE LOSS ATTRIBUTABLE $3.3 MILLION.  Full Article

Genetic Technologies Says Eutillio​ ‍Buccilli To Step Down As CEO
Monday, 5 Feb 2018 

Feb 6 (Reuters) - Genetic Technologies Ltd ::CHANGE OF CHIEF EXECUTIVE OFFICER.EUTILLIO​ ‍BUCCILLI WILL STEP DOWN AS CHIEF EXECUTIVE OFFICER WITH IMMEDIATE EFFECT.‍KASIAN HAS BEEN APPOINTED AS ACTING CEO.  Full Article

Genetic Technologies says FY consolidated revenue $518,506
Tuesday, 29 Aug 2017 

Aug 29 (Reuters) - Genetic Technologies Ltd :FY consolidated revenue from ordinary activities $518,506, down 54 percent.FY consolidated loss attributable to members $8.4 million.  Full Article

Genetic Technologies announces comprehensive review of strategic alternatives
Friday, 25 Aug 2017 

Aug 25 (Reuters) - Genetic Technologies Ltd :Genetic Technologies announces comprehensive review of strategic alternatives.Genetic Technologies Ltd - ‍strategic alternatives include business combination or strategic merger, reverse merger, sale of company or assets​.Genetic Technologies Ltd - ‍strategic alternatives also include in-licensing assets, an acquisition, or other transaction​.  Full Article